CMS Reviewing ICD Implantation Cost Data, Ensuring DRGs Are Correct
This article was originally published in The Gray Sheet
The Centers for Medicare & Medicaid Services (CMS) is evaluating comments on its inpatient prospective payment system (PPS) proposed rule to determine if the actual cost of implanting cardioverter-defibrillators contradicts with the agency's assessment of hospital data on the procedure.
You may also be interested in...
The Medical Device Manufacturers Association is commending CMS' assignment of intravascular brachytherapy devices to the same diagnosis-related group as coronary stents, but is skeptical of the agency's vague reasoning behind the decision.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.